BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2981314)

  • 1. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):163-9. PubMed ID: 2981313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists.
    Leventer SM; Johnson KM
    Life Sci; 1984 Feb; 34(8):793-801. PubMed ID: 6366418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interrelationship between hormones, psychotropic drugs and the opiate receptor--a pilot study.
    Evans G; Groom GV
    Postgrad Med J; 1980; 56 Suppl 1():65-9. PubMed ID: 6248846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
    Hiramatsu M; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the acute administration of buprenorphine hydrochloride on the release of anterior pituitary hormones in the rat: evidence for the involvement of multiple opiate receptors.
    Pechnick RN; George R; Poland RE
    Life Sci; 1985 Nov; 37(20):1861-8. PubMed ID: 2997571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.